Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments

By Locati Laura D.   Licitra Lisa   Agate Laura   Ou Sai-Hong I.   Boucher Andree   Jarzab Barbara   Qin Shukui   Kane Madeleine A.   Wirth Lori J.   Chen Connie   Kim Sinil   Ingrosso Antonella   Pithavala Yazdi K.   Bycott Paul   Cohen Ezra E. W.  

Cancer, Vol. 120, Iss. 17, 2014-09 ,pp. : 2694-2703

Blackwell Publishing

Access to resources Recommend Favorite

Quality-of-Life Assessment in Phase III Clinical Trials of Gemcitabine in Non-Small-Cell Lung Cancer

By Reynolds Jonathan K.  

Drugs & Aging, Vol. 25, Iss. 11, 2008-01 ,pp. : 893-911

Adis International

Access to resources Recommend Favorite

Epigenetic transitions: towards therapeutic targets

By Kalebic Thea  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 6, 2003-12 ,pp. : 693-699

Informa Healthcare

Access to resources Recommend Favorite

Assessing the Geriatric Patient: Planning for transitions of care

By Moore Irene  

The Consultant Pharmacist, Vol. 29, Iss. 6, 2014-06 ,pp. : 369-374

American Society of Consultant Pharmacists

Access to resources Recommend Favorite